These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 15841298)

  • 1. Radiation dose rate and urinary activity in patients with differentiated thyroid carcinoma treated with radioiodine-131; a survey in Iranian population.
    Shahhosseini S; Beiki D; Dadashzadeh S; Eftekhari M; Tayebi H; Moosazadeh Rashti G
    Hell J Nucl Med; 2004; 7(3):192-4. PubMed ID: 15841298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation period prediction in patients with differentiated thyroid carcinoma treated after thyroidectomy by radioiodine-131.
    Markou P; Chatzopoulos D
    Hell J Nucl Med; 2004; 7(3):195-8. PubMed ID: 15841299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
    Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiation exposure in the environment of patients after application of radiopharmaceuticals. Part 2: Therapeutic procedures].
    Sudbrock F; Boldt F; Kobe C; Hammes J; Eschner W; Schicha H
    Nuklearmedizin; 2009; 48(1):17-25. PubMed ID: 19212607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
    de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
    Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
    Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
    Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
    Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
    Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
    Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
    J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radiation badge survey for family members living with patients treated with a (103)Pd permanent breast seed implant.
    Keller BM; Pignol JP; Rakovitch E; Sankreacha R; O'Brien P
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):267-71. PubMed ID: 17967512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.
    Hänscheid H; Lassmann M; Luster M; Kloos RT; Reiners C
    Endocr Relat Cancer; 2009 Dec; 16(4):1283-9. PubMed ID: 19628649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation exposure after permanent prostate brachytherapy.
    Cattani F; Vavassori A; Polo A; Rondi E; Cambria R; Orecchia R; Tosi G
    Radiother Oncol; 2006 Apr; 79(1):65-9. PubMed ID: 16564593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionated doses of radioiodine for ablation of postsurgical thyroid tissue remnants.
    Arad E; Flannery K; Wilson GA; O'Mara RE
    Clin Nucl Med; 1990 Oct; 15(10):676-7. PubMed ID: 2225668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma.
    Bal C; Padhy AK; Jana S; Pant GS; Basu AK
    Cancer; 1996 Jun; 77(12):2574-80. PubMed ID: 8640708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measurement of incorporation in family members of radioiodine therapy patients after therapy of benign thyroid diseases].
    Lassmann M; Hänscheid H; Schelper LF; Körber C; Reiners C
    Nuklearmedizin; 1998 May; 37(3):120-3. PubMed ID: 9604233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.